Stay updated on Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page.

Latest updates to the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page
- Check6 days agoChange DetectedResults have been posted and a results section added, including primary and secondary outcomes (ORR at 6 months, non-progression at 6 months, PFS, OS) with specified timeframes. Links to the Study Protocol and Statistical Analysis Plan are now available, and study results timing (Results First Posted/Submitted) has been updated.SummaryDifference8%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe PubMed publications note text was updated to indicate automatic population from PubMed. The page revision version was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check35 days agoChange DetectedRemoved the general government funding/operating status notice from the page; no study-specific content was changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check49 days agoChange DetectedComparison of the old and new screenshots shows no substantive changes to the study details (title, conditions, interventions, outcomes, eligibility criteria, locations); content appears unchanged aside from minor formatting tweaks. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check77 days agoChange DetectedAdded government funding notice and NIH Clinical Center operating status, added new content term “Bone osteosarcoma,” and updated revision version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check85 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page.